Nima Mosammaparast, Thaddeus Stappenbeck, Joshua Swamidass, Gene Oltz and Kathleen Sheehan among awardees in November and December with grants totaling nearly $3 million.
Nima Mosammaparast, MD, PhD, Assistant Professor of Pathology & Immunology, received a two-year $600,000 grant from the Alvin Siteman Cancer Research Fund, entitled “Targeting Nuclear Alkylation Repair Centers for Tumor Chemosensitization”.
Thaddeus Stappenbeck, MD, PhD, Professor of Pathology & Immunology and of Developmental Biology, and Co-Chief, Division of Laboratory and Genomic Medicine, received a three-year $1,500,000 grant from the Crohn’s and Colitis Foundation of America, entitled “An Inside-Out, Outside-In Mechanism Leading to Recurrent and Persistent Damage in Cd”.
Joshua Swamidass, MD, PhD, Assistant Professor of Pathology and Immunology and of Biomedical Engineering, received a four-year $157,482 grant from the National Institutes of Health, entitled “Computationally Modeling the Impact of Ontogeny on Drug Metabolic Fate”.
Eugene Oltz, PhD, Professor of Pathology and Immunology, received a five-year $266,875 grant from the National Institutes of Health, entitled “GSK3B in TCR Repertoire and Immune Disease”.
Kathleen Sheehan, PhD, Assistant Professor of Pathology and Immunology, received two-year $397,859 grant from Neon Therapeutics, entitled “Novel Protocols for Personalized Cancer Vaccines Using a Schreiber Lab Preclinicalsarcoma Model”.